Weekly epirubicin plus docetaxel as first-line treatment in metastatic breast cancer

T. Gamucci, A. M. D'Ottavio, E. Magnolfi, M. Barduagni, A. Vaccaro, I. Sperduti, L. Moscetti, F. Belli, L. Meliffi

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Weekly epirubicin plus docetaxel as first-line treatment in metastatic breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences